Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
RG-6631 by F. Hoffmann-La Roche for Autoimmune Disorders: Likelihood of Approval
RG-6631 is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Autoimmune Disorders. According to GlobalData,...
Data Insights
RG-6631 by F. Hoffmann-La Roche for Ulcerative Colitis: Likelihood of Approval
RG-6631 is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Ulcerative Colitis. According to GlobalData,...